The role of fibroblast growth factors in tumor growth

Murray Korc, R. E. Friesel

Research output: Contribution to journalArticle

184 Citations (Scopus)

Abstract

Biological processes that drive cell growth are exciting targets for cancer therapy. The fibroblast growth factor (FGF) signaling network plays a ubiquitous role in normal cell growth, survival, differentiation, and angiogenesis, but has also been implicated in tumor development. Elucidation of the roles and relationships within the diverse FGF family and of their links to tumor growth and progression will be critical in designing new drug therapies to target FGF receptor (FGFR) pathways. Recent studies have shown that FGF can act synergistically with vascular endothelial growth factor (VEGF) to amplify tumor angiogenesis, highlighting that targeting of both the FGF and VEGF pathways may be more efficient in suppressing tumor growth and angiogenesis than targeting either factor alone. In addition, through inducing tumor cell survival, FGF has the potential to overcome chemotherapy resistance highlighting that chemotherapy may be more effective when used in combination with FGF inhibitor therapy. Furthermore, FGFRs have variable activity in promoting angiogenesis, with the FGFR-1 subgroup being associated with tumor progression and the FGFR-2 subgroup being associated with either early tumor development or decreased tumor progression. This review highlights the growing knowledge of FGFs in tumor cell growth and survival, including an overview of FGF intracellular signaling pathways, the role of FGFs in angiogenesis, patterns of FGF and FGFR expression in various tumor types, and the role of FGFs in tumor progression.

Original languageEnglish (US)
Pages (from-to)639-651
Number of pages13
JournalCurrent Cancer Drug Targets
Volume9
Issue number5
DOIs
StatePublished - Aug 2009
Externally publishedYes

Fingerprint

Fibroblast Growth Factors
Fibroblast Growth Factor Receptors
Growth
Neoplasms
Cell Survival
Drug Therapy
Vascular Endothelial Growth Factor A
Biological Phenomena
Fibroblast Growth Factor 1
Growth Inhibitors
Fibroblast Growth Factor 2

Keywords

  • Angiogenesis/neovascularization
  • Fibroblast growth factors
  • Gene expression regulation
  • Molecular targets
  • Neoplasms

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Cancer Research

Cite this

The role of fibroblast growth factors in tumor growth. / Korc, Murray; Friesel, R. E.

In: Current Cancer Drug Targets, Vol. 9, No. 5, 08.2009, p. 639-651.

Research output: Contribution to journalArticle

Korc, Murray ; Friesel, R. E. / The role of fibroblast growth factors in tumor growth. In: Current Cancer Drug Targets. 2009 ; Vol. 9, No. 5. pp. 639-651.
@article{292682407fb6429896b7b452f5f52c10,
title = "The role of fibroblast growth factors in tumor growth",
abstract = "Biological processes that drive cell growth are exciting targets for cancer therapy. The fibroblast growth factor (FGF) signaling network plays a ubiquitous role in normal cell growth, survival, differentiation, and angiogenesis, but has also been implicated in tumor development. Elucidation of the roles and relationships within the diverse FGF family and of their links to tumor growth and progression will be critical in designing new drug therapies to target FGF receptor (FGFR) pathways. Recent studies have shown that FGF can act synergistically with vascular endothelial growth factor (VEGF) to amplify tumor angiogenesis, highlighting that targeting of both the FGF and VEGF pathways may be more efficient in suppressing tumor growth and angiogenesis than targeting either factor alone. In addition, through inducing tumor cell survival, FGF has the potential to overcome chemotherapy resistance highlighting that chemotherapy may be more effective when used in combination with FGF inhibitor therapy. Furthermore, FGFRs have variable activity in promoting angiogenesis, with the FGFR-1 subgroup being associated with tumor progression and the FGFR-2 subgroup being associated with either early tumor development or decreased tumor progression. This review highlights the growing knowledge of FGFs in tumor cell growth and survival, including an overview of FGF intracellular signaling pathways, the role of FGFs in angiogenesis, patterns of FGF and FGFR expression in various tumor types, and the role of FGFs in tumor progression.",
keywords = "Angiogenesis/neovascularization, Fibroblast growth factors, Gene expression regulation, Molecular targets, Neoplasms",
author = "Murray Korc and Friesel, {R. E.}",
year = "2009",
month = "8",
doi = "10.2174/156800909789057006",
language = "English (US)",
volume = "9",
pages = "639--651",
journal = "Current Cancer Drug Targets",
issn = "1568-0096",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - The role of fibroblast growth factors in tumor growth

AU - Korc, Murray

AU - Friesel, R. E.

PY - 2009/8

Y1 - 2009/8

N2 - Biological processes that drive cell growth are exciting targets for cancer therapy. The fibroblast growth factor (FGF) signaling network plays a ubiquitous role in normal cell growth, survival, differentiation, and angiogenesis, but has also been implicated in tumor development. Elucidation of the roles and relationships within the diverse FGF family and of their links to tumor growth and progression will be critical in designing new drug therapies to target FGF receptor (FGFR) pathways. Recent studies have shown that FGF can act synergistically with vascular endothelial growth factor (VEGF) to amplify tumor angiogenesis, highlighting that targeting of both the FGF and VEGF pathways may be more efficient in suppressing tumor growth and angiogenesis than targeting either factor alone. In addition, through inducing tumor cell survival, FGF has the potential to overcome chemotherapy resistance highlighting that chemotherapy may be more effective when used in combination with FGF inhibitor therapy. Furthermore, FGFRs have variable activity in promoting angiogenesis, with the FGFR-1 subgroup being associated with tumor progression and the FGFR-2 subgroup being associated with either early tumor development or decreased tumor progression. This review highlights the growing knowledge of FGFs in tumor cell growth and survival, including an overview of FGF intracellular signaling pathways, the role of FGFs in angiogenesis, patterns of FGF and FGFR expression in various tumor types, and the role of FGFs in tumor progression.

AB - Biological processes that drive cell growth are exciting targets for cancer therapy. The fibroblast growth factor (FGF) signaling network plays a ubiquitous role in normal cell growth, survival, differentiation, and angiogenesis, but has also been implicated in tumor development. Elucidation of the roles and relationships within the diverse FGF family and of their links to tumor growth and progression will be critical in designing new drug therapies to target FGF receptor (FGFR) pathways. Recent studies have shown that FGF can act synergistically with vascular endothelial growth factor (VEGF) to amplify tumor angiogenesis, highlighting that targeting of both the FGF and VEGF pathways may be more efficient in suppressing tumor growth and angiogenesis than targeting either factor alone. In addition, through inducing tumor cell survival, FGF has the potential to overcome chemotherapy resistance highlighting that chemotherapy may be more effective when used in combination with FGF inhibitor therapy. Furthermore, FGFRs have variable activity in promoting angiogenesis, with the FGFR-1 subgroup being associated with tumor progression and the FGFR-2 subgroup being associated with either early tumor development or decreased tumor progression. This review highlights the growing knowledge of FGFs in tumor cell growth and survival, including an overview of FGF intracellular signaling pathways, the role of FGFs in angiogenesis, patterns of FGF and FGFR expression in various tumor types, and the role of FGFs in tumor progression.

KW - Angiogenesis/neovascularization

KW - Fibroblast growth factors

KW - Gene expression regulation

KW - Molecular targets

KW - Neoplasms

UR - http://www.scopus.com/inward/record.url?scp=69249216604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69249216604&partnerID=8YFLogxK

U2 - 10.2174/156800909789057006

DO - 10.2174/156800909789057006

M3 - Article

C2 - 19508171

AN - SCOPUS:69249216604

VL - 9

SP - 639

EP - 651

JO - Current Cancer Drug Targets

JF - Current Cancer Drug Targets

SN - 1568-0096

IS - 5

ER -